logo

News & Media Hub

Catch Up on the Latest News and Media Releases from Syndicate Bio

announcements

Syndicate Bio Partners with National Institute of Cancer Research and Treatment (NICRAT) to Tackle Cancer Disparities in Nigeria with Cancer Genome Project

October 24, 2023

Syndicate Bio has entered into a Memorandum of Understanding with the National Institute of Cancer Research and Treatment (NICRAT), Nigeria's premier institution for cancer research, treatment, and control. Their collaborative initiative focuses on studying the most common cancers in Nigeria, providing valuable insights into their genomic profiles to enhance diagnosis, treatment, and support clinical and pre-clinical research.

Read More

Syndicate Bio Partners with Nigerian Institute of Medical Research for Innovative Genomic Drug Discovery in Nigeria

October 18, 2023

Syndicate Bio has signed a significant Memorandum of Understanding with Nigeria's leading research institution, the Nigerian Institute of Medical Research, paving the way for transformative genomic studies in infectious and non-infectious diseases and drug discovery in Nigeria.

Read More

Syndicate Bio Presented at the Women of Color in Pharma Summit

September 11, 2023

At the recently concluded Women of Color in Pharma Inaugural Global Summit, our CEO, Dr. Abasi Ene-Obong, delivered a presentation titled ‘The Value Proposition for Doing Business on the Continent.'

Read More

Syndicate Bio Participated at the 2023 World Health Summit

September 11, 2023

At the 2023 World Health Summit, our Co-founder and Chief Scientific Officer, Dr Jumi Popoola, delivered a presentation on the ‘Use of predictive genomics to drive healthcare in resource-limited settings.’

Read More

Syndicate Bio Presented at the 2023 AAADV Workshop

September 11, 2023

At the 2023 AAADV Workshop, our CEO, Dr Abasi Ene-Obong spoke on 'Genomic Testing in Low-and Middle-Income Countries.'

Read More

media Highlights

A Visual Showcase of Our Impact

Get in touch with us

Contact Us